Veeva Clinical Database (CDB) enables innovative ways of managing clinical trial data, saving customers 30 to 50% of the time required to aggregate, clean, and transform data. Since Veeva Systems (NYSE: VEEV) announced its launch, Veeva CDB has cleaned more than 200,000 subjects to quickly provide quality data across more than 200 studies.
"By launching Veeva CDB and building processes around it, we're laying a foundation for clinical data transformation," said Jerry Yarem, vice president, data management, Fortrea. "This is a significant advancement that can bring together all of our data sources and deliver clean data faster than ever so study teams can make data-driven decisions with confidence."
Veeva CDB automates processes for a new way of cleaning data that increases productivity and efficiency. Using Veeva CDB Auto Checks, customers can automatically identify discrepancies upon data ingestion and create queries or close them when issues are corrected. The application also automates change detection so data managers can focus efforts on new or updated data, saving time and lowering costs.
"Veeva CDB makes collaboration with study partners and data providers easy, simplifying data transfer and configuration," said Tonya Arthur, head of data management, Acelyrin. "Pairing Veeva's clinical data management platform and our CRO partner's expertise will improve our trial processes and provide the visibility to make informed decisions that can positively impact trial outcomes."
Sponsors and contract research organizations (CROs) use Veeva CDB to ingest and clean clinical data from a variety of system sources, including EDC systems such as Veeva Vault EDC and Medidata Rave™, ePRO, and lab data. This allows sponsors to standardize and optimize processes for effective data management across systems. In addition, the Veeva CDB Data Provider Program enables qualified partners with resources to gain operational efficiencies when delivering data for Veeva CDB customers.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.